The board of directors of the China Jiuhao Health Industry Corporation Limited announced that based on the Group's preliminary unaudited assessment for the year ended 31 December 2015, the Group is expected to record an annual consolidated net loss attributable to equity shareholders of the Company for the Year of approximately HKD 500 million, whereas the Group recorded a net profit attributable to equity shareholders of the Company for the year ended 31 December 2014 of HKD 55 million. The expected net loss is primarily due to the incurrence of loss on disposal of subsidiaries, after taxes, of approximately HKD 300 million, which is mainly attributed to the completion of a very substantial disposal transaction ("VSD") in October 2015; the incurrence of legal and professional fees of approximately HKD 54 million for the VSD provision for impairment of certain non-current assets and current assets of the Group of approximately HKD 190 million, which is mainly attributed to the provision for impairment of the interests in joint ventures and the amounts due from joint ventures and its subsidiaries the incurrence of exchange loss arising from depreciation of Renminbi against Hong Kong dollars during the Year of approximately HKD 34 million.